Novo’s main Ozempic plant cited for quality lapses by FDA admin 1 week ago News Comments Off on Novo’s main Ozempic plant cited for quality lapses by FDA 0 Views Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand. Read More Share Facebook Twitter Stumbleupon LinkedIn Pinterest
